{"id":"kalcipos-d","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypercalcemia"},{"rate":null,"effect":"Hyperphosphatemia"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Constipation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Calcipotriol is a synthetic vitamin D3 analog that binds to vitamin D receptors to enhance intestinal calcium absorption and regulate serum calcium and phosphate levels. The addition of calcium carbonate provides supplemental elemental calcium. Together, these components work to correct hypocalcemia and support bone health in patients with vitamin D deficiency or impaired calcium metabolism.","oneSentence":"Kalcipos-D combines calcipotriol (a vitamin D analog) with calcium carbonate to regulate calcium and phosphate metabolism and promote bone mineralization.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:50:53.628Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypocalcemia and vitamin D deficiency"},{"name":"Secondary hyperparathyroidism"},{"name":"Osteoporosis prevention and treatment"}]},"trialDetails":[{"nctId":"NCT02457247","phase":"PHASE4","title":"Calcichew D3 Preference Study in Participants Eligible for Calcium and Vitamin D Supplementation.","status":"COMPLETED","sponsor":"Takeda","startDate":"2015-06","conditions":"Calcium and Vitamin D Deficiencies","enrollment":276},{"nctId":"NCT02922803","phase":"NA","title":"Vitamin D and Physical Performance Before and After Intervention and Birth Outcome in Pregnant Somali and Swedish Women","status":"COMPLETED","sponsor":"Uppsala University","startDate":"2010-05","conditions":"Muscle Weakness, Vitamin D Deficiency","enrollment":123}],"_emaApprovals":[],"_faersSignals":[{"count":56,"reaction":"FATIGUE"},{"count":55,"reaction":"NAUSEA"},{"count":43,"reaction":"PYREXIA"},{"count":42,"reaction":"DYSPNOEA"},{"count":42,"reaction":"HEADACHE"},{"count":39,"reaction":"DIARRHOEA"},{"count":36,"reaction":"DIZZINESS"},{"count":30,"reaction":"PAIN IN EXTREMITY"},{"count":28,"reaction":"ATRIAL FIBRILLATION"},{"count":28,"reaction":"DRUG INTERACTION"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Kalcipos-D","genericName":"Kalcipos-D","companyName":"Takeda","companyId":"takeda","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Kalcipos-D combines calcipotriol (a vitamin D analog) with calcium carbonate to regulate calcium and phosphate metabolism and promote bone mineralization. Used for Hypocalcemia and vitamin D deficiency, Secondary hyperparathyroidism, Osteoporosis prevention and treatment.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}